// App-Quantinova.ai

TCT-749 : Heparin Versus Bivalirudin In-hospital And 30 Day MACE In Patients Having DES Implantation

Researchers

Presenter

  • Evan Shlofmitz

Principal Investigators

  • Richard Shlofmitz

  • Simcha Pollack

  • Elizabeth Cormier

  • Elizabeth Haag

  • Nathaniel Reichek

Medical Centers

  • New York Hospital Queens, New York City, NY

  • St. Francis Hospital-The Heart Center, Roslyn, NY

  • St. Francis Hospital, Roslyn, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved